Sarepta Therapeutics (SRPT) Change in Inventory (2016 - 2026)

Sarepta Therapeutics has reported Change in Inventory for 11 years, with the latest figure at $69.8 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 60.67% year-over-year to $69.8 million; the trailing twelve-month figure through Mar 2026 stood at $193.5 million (down 62.21% YoY), and the FY2025 full-year result was $301.1 million, down 23.81% from the prior year.
• Change in Inventory for Q1 2026 stood at $69.8 million, up from -$18.5 million in the prior quarter.
• The five-year high for Change in Inventory was $177.4 million in Q1 2025, with the low at -$18.5 million in Q4 2025.
• Average Change in Inventory over 5 years is $56.7 million, with a median of $59.2 million recorded in 2025.
• Year-over-year, Change in Inventory surged 19675.16% in 2024 and plunged 111.43% in 2025.
• Tracing SRPT's Change in Inventory over 5 years: stood at $8.9 million in 2022, then jumped by 959.73% to $94.1 million in 2023, then surged by 71.79% to $161.7 million in 2024, then sank by 111.43% to -$18.5 million in 2025, then soared by 477.57% to $69.8 million in 2026.
• The last three Change in Inventory figures came in at $69.8 million (Q1 2026), -$18.5 million (Q4 2025), and $83.0 million (Q3 2025), per Business Quant data.

Peer Comparison